当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析 - 现金流量表

浙江医药

(600216)

  

流通市值:119.40亿  总市值:120.69亿
流通股本:9.51亿   总股本:9.62亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,446,912,451.92,103,549,287.059,008,442,586.917,005,114,859.74
  收到的税费返还153,007,705.8782,465,625.54417,886,143.15398,671,381.35
  收到其他与经营活动有关的现金53,329,290.123,568,085.16131,107,086.65113,340,958.01
  经营活动现金流入小计4,653,249,447.872,209,582,997.759,557,435,816.717,517,127,199.1
  购买商品、接受劳务支付的现金2,629,174,755.091,259,867,312.614,655,661,305.813,681,699,974.68
  支付给职工以及为职工支付的现金552,977,371.09347,557,871.83977,201,556.15774,221,238.49
  支付的各项税费432,800,641.56230,010,525.87815,944,497.28698,622,952.68
  支付其他与经营活动有关的现金586,046,983.97272,131,480.941,222,859,746.2873,917,259.34
  经营活动现金流出小计4,200,999,751.712,109,567,191.257,671,667,105.446,028,461,425.19
  经营活动产生的现金流量净额452,249,696.16100,015,806.51,885,768,711.271,488,665,773.91
二、投资活动产生的现金流量:
  收回投资收到的现金858,075,163.9356,526,269.31,267,448,330.49824,723,419.38
  取得投资收益收到的现金211,259.6760,000713,015.21500,558.14
  处置固定资产、无形资产和其他长期资产收回的现金净额93,85059,5001,865,875.011,161,360.29
  收到的其他与投资活动有关的现金379,470,541.55150,421,531.13848,065,067.62695,205,845.38
  投资活动现金流入小计1,237,850,815.12507,067,300.432,118,092,288.331,521,591,183.19
  购建固定资产、无形资产和其他长期资产支付的现金271,332,856.21167,379,534.18446,471,610.05288,220,093.07
  投资支付的现金980,640,358.66576,203,507.321,261,067,492.56838,899,992.56
  支付其他与投资活动有关的现金706,000,060150,000,000782,500,000637,500,000
  投资活动现金流出小计1,957,973,274.87893,583,041.52,490,039,102.611,764,620,085.63
  投资活动产生的现金流量净额-720,122,459.75-386,515,741.07-371,946,814.28-243,028,902.44
三、筹资活动产生的现金流量:
  吸收投资收到的现金357,975,658.3141,100,000--
  其中:子公司吸收少数股东投资收到的现金357,975,658.3141,100,000--
  取得借款收到的现金597,829,866.72300,000,000695,000,000546,577,625.82
  收到其他与筹资活动有关的现金75,360,941.57-74,781,200-
  筹资活动现金流入小计1,031,166,466.6341,100,000769,781,200546,577,625.82
  偿还债务支付的现金505,000,000209,000,000577,000,000341,500,000
  分配股利、利润或偿付利息支付的现金11,287,744.324,763,445.88376,692,920.16370,696,311.34
  支付其他与筹资活动有关的现金456,236.61-218,950,936.68202,029,611.85
  筹资活动现金流出小计516,743,980.93213,763,445.881,172,643,856.84914,225,923.19
  筹资活动产生的现金流量净额514,422,485.67127,336,554.12-402,862,656.84-367,648,297.37
四、汇率变动对现金及现金等价物的影响-48,739,999.02-30,817,344.9290,287,386.8855,426,355.68
五、现金及现金等价物净增加额197,809,723.06-189,980,725.371,201,246,627.03933,414,929.78
  加:期初现金及现金等价物余额3,166,832,038.093,166,832,038.091,965,585,411.061,965,585,411.06
  期末现金及现金等价物余额3,364,641,761.152,976,851,312.723,166,832,038.092,899,000,340.84
补充资料:
  净利润515,563,144.33-760,239,195-
  资产减值准备25,665,359.76-202,120,062.39-
  固定资产和投资性房地产折旧340,982,371.51-693,793,030.97-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧340,982,371.51-693,793,030.97-
  无形资产摊销11,126,767.22-98,905,655.78-
  长期待摊费用摊销1,691,033.58-4,463,475.09-
  处置固定资产、无形资产和其他长期资产的损失-18,703.79-81,154.73-
  固定资产报废损失329,299.82-6,478,423.46-
  公允价值变动损失-19,167,315.83--4,642,415.19-
  财务费用88,683,122.68--50,099,758.19-
  投资损失-29,479,499.11--2,847,078.19-
  递延所得税12,281,128.32--493,100.39-
  其中:递延所得税资产减少12,281,128.32--493,100.39-
  存货的减少-249,803,107.07-32,699,842.33-
  经营性应收项目的减少-92,346,344.75-144,042,273.57-
  经营性应付项目的增加-236,515,801.36--6,169,282.34-
  其他79,714,790.28-11,897,682.86-
  现金的期末余额3,364,641,761.15-3,166,832,038.09-
  减:现金的期初余额3,166,832,038.09-1,965,585,411.06-
  现金及现金等价物的净增加额197,809,723.06-1,201,246,627.03-
公告日期2026-08-262026-04-242026-04-112025-10-28
审计意见(境内)标准无保留意见
TOP↑